Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Hyperbranched polydendrons: a new nanomaterials platform with tuneable permeation through model gut epithelium.

Hatton FL, Tatham LM, Tidbury LR, Chambon P, He T, Owen A, Rannard SP.

Chem Sci. 2015 Jan 1;6(1):326-334. doi: 10.1039/c4sc02889a. Epub 2014 Oct 3.

2.

Nanomedicine for safe healing of bone trauma: Opportunities and challenges.

Behzadi S, Luther GA, Harris MB, Farokhzad OC, Mahmoudi M.

Biomaterials. 2017 Nov;146:168-182. doi: 10.1016/j.biomaterials.2017.09.005. Epub 2017 Sep 4. Review.

3.

Lipophilic siRNA targets albumin in situ and promotes bioavailability, tumor penetration, and carrier-free gene silencing.

Sarett SM, Werfel TA, Lee L, Jackson MA, Kilchrist KV, Brantley-Sieders D, Duvall CL.

Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6490-E6497. doi: 10.1073/pnas.1621240114. Epub 2017 Jul 24.

PMID:
28739942
4.
5.

ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.

Xu X, Saw PE, Tao W, Li Y, Ji X, Bhasin S, Liu Y, Ayyash D, Rasmussen J, Huo M, Shi J, Farokhzad OC.

Adv Mater. 2017 Sep;29(33). doi: 10.1002/adma.201700141. Epub 2017 Jul 6.

6.

Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo.

Zhu X, Tao W, Liu D, Wu J, Guo Z, Ji X, Bharwani Z, Zhao L, Zhao X, Farokhzad OC, Shi J.

Theranostics. 2017 May 12;7(7):1990-2002. doi: 10.7150/thno.18136. eCollection 2017.

7.

Cancer drug delivery in the nano era: An overview and perspectives (Review).

Li Z, Tan S, Li S, Shen Q, Wang K.

Oncol Rep. 2017 Aug;38(2):611-624. doi: 10.3892/or.2017.5718. Epub 2017 Jun 14.

8.

Pluronic F127 and D-α-Tocopheryl Polyethylene Glycol Succinate (TPGS) Mixed Micelles for Targeting Drug Delivery across The Blood Brain Barrier.

Meng X, Liu J, Yu X, Li J, Lu X, Shen T.

Sci Rep. 2017 Jun 7;7(1):2964. doi: 10.1038/s41598-017-03123-y.

9.

Design of Insulin-Loaded Nanoparticles Enabled by Multistep Control of Nanoprecipitation and Zinc Chelation.

Chopra S, Bertrand N, Lim JM, Wang A, Farokhzad OC, Karnik R.

ACS Appl Mater Interfaces. 2017 Apr 5;9(13):11440-11450. doi: 10.1021/acsami.6b16854. Epub 2017 Mar 21.

PMID:
28323414
10.

Targeted nanoparticles encapsulating (-)-epigallocatechin-3-gallate for prostate cancer prevention and therapy.

Sanna V, Singh CK, Jashari R, Adhami VM, Chamcheu JC, Rady I, Sechi M, Mukhtar H, Siddiqui IA.

Sci Rep. 2017 Feb 1;7:41573. doi: 10.1038/srep41573.

11.

Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.

Sanchez-Gaytan BL, Fay F, Hak S, Alaarg A, Fayad ZA, Pérez-Medina C, Mulder WJ, Zhao Y.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2923-2926. doi: 10.1002/anie.201611288. Epub 2017 Jan 23.

PMID:
28112478
12.

Nanoparticle-based strategy for personalized B-cell lymphoma therapy.

Martucci NM, Migliaccio N, Ruggiero I, Albano F, Calì G, Romano S, Terracciano M, Rea I, Arcari P, Lamberti A.

Int J Nanomedicine. 2016 Nov 16;11:6089-6101. eCollection 2016.

13.

Cancer nanomedicine: progress, challenges and opportunities.

Shi J, Kantoff PW, Wooster R, Farokhzad OC.

Nat Rev Cancer. 2017 Jan;17(1):20-37. doi: 10.1038/nrc.2016.108. Epub 2016 Nov 11. Review.

14.

Nanomedicines for renal disease: current status and future applications.

Kamaly N, He JC, Ausiello DA, Farokhzad OC.

Nat Rev Nephrol. 2016 Dec;12(12):738-753. doi: 10.1038/nrneph.2016.156. Epub 2016 Oct 31. Review.

15.

Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.

Jha S, Ramadori F, Quarta S, Biasiolo A, Fabris E, Baldan P, Guarino G, Ruvoletto M, Villano G, Turato C, Gatta A, Mancin F, Pontisso P, Scrimin P.

Bioconjug Chem. 2017 Jan 18;28(1):222-229. doi: 10.1021/acs.bioconjchem.6b00441. Epub 2016 Nov 2.

16.

Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.

Petrenko VA, Gillespie JW.

Expert Opin Drug Deliv. 2017 Mar;14(3):373-384. doi: 10.1080/17425247.2016.1218463. Epub 2016 Aug 5. Review.

PMID:
27466706
17.

Erythrocyte-derived nano-probes functionalized with antibodies for targeted near infrared fluorescence imaging of cancer cells.

Mac JT, Nuñez V, Burns JM, Guerrero YA, Vullev VI, Anvari B.

Biomed Opt Express. 2016 Mar 16;7(4):1311-22. doi: 10.1364/BOE.7.001311. eCollection 2016 Apr 1.

18.

Recent Developments of Liposomes as Nanocarriers for Theranostic Applications.

Xing H, Hwang K, Lu Y.

Theranostics. 2016 Jun 15;6(9):1336-52. doi: 10.7150/thno.15464. eCollection 2016. Review.

19.

Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery.

Habibi N, Kamaly N, Memic A, Shafiee H.

Nano Today. 2016 Feb;11(1):41-60.

20.

Targeted Interleukin-10 Nanotherapeutics Developed with a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis.

Kamaly N, Fredman G, Fojas JJ, Subramanian M, Choi WI, Zepeda K, Vilos C, Yu M, Gadde S, Wu J, Milton J, Carvalho Leitao R, Rosa Fernandes L, Hasan M, Gao H, Nguyen V, Harris J, Tabas I, Farokhzad OC.

ACS Nano. 2016 May 24;10(5):5280-92. doi: 10.1021/acsnano.6b01114. Epub 2016 Apr 28.

Supplemental Content

Support Center